Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates.
about
Recognition of Lewis x derivatives present on mucins by flagellar components of Pseudomonas aeruginosa.Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement AttackClusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses
P2860
Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Clusterin, a putative compleme ...... ccus aureus clinical isolates.
@en
Clusterin, a putative compleme ...... ccus aureus clinical isolates.
@nl
type
label
Clusterin, a putative compleme ...... ccus aureus clinical isolates.
@en
Clusterin, a putative compleme ...... ccus aureus clinical isolates.
@nl
prefLabel
Clusterin, a putative compleme ...... ccus aureus clinical isolates.
@en
Clusterin, a putative compleme ...... ccus aureus clinical isolates.
@nl
P2093
P2860
P1476
Clusterin, a putative compleme ...... ccus aureus clinical isolates.
@en
P2093
P2860
P304
P407
P577
1996-10-01T00:00:00Z